ADMA Court Alert: ADMA Biologics Investors Seeking to Recover Losses in Securities Fraud Class Action are Notified to Contact BFA Law before August 10 Deadline
Bleichmar Fonti & Auld LLP announced a class action lawsuit against ADMA Biologics alleging securities fraud related to a channel stuffing scheme. The firm reminds investors that the lead plaintiff deadline is August 10, 2026, with claims that reported growth was inflated by undisclosed related-party transactions.
Key figures
- Case number
- 26-cv-6918
- Lead plaintiff deadline
- August 10, 2026
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.